Top 5 of publications 2015-2019
- Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
Authors: Robertson, J., Bondarenko, I., Trishkina, E., Dvorkin, M., Panasci, L., Manikhas, A., Shparyk, Y., Cardona-Huerta, S., Cheung, K., Philco-Salas, M., Ruiz-Borrego, M., Shao, Z., Noguchi, S., Rowbottom, J., Stuart, M., Grinsted, L., Fazal, M., & Ellis, M.
- Progress and remaining challenges for cancer control in Latin America and the Caribbean
Authors: Strasser-Weippl, K., Chavarri-Guerra, Y., Villarreal-Garza, C., Bychkovsky, B., Debiasi, M., Liedke, P., Soto-Perez-de-Celis, E., Dizon, D., Cazap, E., de Lima Lopes, G., Touya, D., Nunes, J., Louis, J., Vail, C., Bukowski, A., Ramos-Elias, P., Unger-Saldaña, K., Brandao, D., Ferreyra, M., Luciani, S., Nogueira-Rodrigues, A., de Carvalho Calabrich, A., Del Carmen, M., Rauh-Hain, J., Schmeler, K., Sala, R., & Goss, P.
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Authors: Rebbeck, T. Friebel, T., Villarreal-Garza, C., von Wachenfeldt, A., Walker, L., et al.
- Lipids and Oxidative Stress Associated with Ethanol-Induced Neurological Damage
Authors: Hernández, J., López-Sánchez, R., & Rendón-Ramírez, A.
- The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer
Authors: Villarreal-Garza, C., Weitzel, J., Llacuachaqui, M., Sifuentes, E., Magallanes-Hoyos, M., Gallardo, L., Alvarez-Gómez, R., Herzog, J., Castillo, D., Royer, R., Akbari, M., Lara-Medina, F., Herrera, L., Mohar, A., & Narod, S.